We have compared dendritic cells (DC) isolated from mouse spleen, or generated in vitro from bone marrow (BM) precursors cultured in granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin-4 (IL-41, for the ability to process and present soluble antigen and stimulate major histocompatibility complex (MHCI Class 11-restricted T cells. DC from spleen or BM cultures were equally able to stimulate the in vitro proliferation of allogeneic T cells or of antigen-specific T-cell receptor (TCR)-transgenic T cells. Both DC populations also induced comparable levels of IL-2 secretion by a T-cell hybridoma. Therefore, splenic and BM-derived DC express comparable levels of (Antigen + MHC Class Ill ligands andlor costimulatory molecules and have comparable ENDRITIC CELLS (DC) are powerful antigen present-D ing cells (APC) found in skin, airway, and gut mucosa in lymphoid tissue and blood.' DC reside in tissues in an immature or nonactivated form characterized by active uptake and processing of antigen,' and expression of low levels of T-cell costimulatory molecules. Upon activation, DC are thought to leave tissues and migrate to secondary lymphoid organs where they interact with T lymphocytes and initiate immune responses. Activation is accompanied by the loss of ability to endocytose and process antigen,* and by the acquisition of ability to stimulate T lymphocytes through upregulation of T-cell costimulatory molecules.3 Cognate interaction with T cells further upregulates expression of Tcell costimulatory molecules on DC?
volve their in vitro growth and differentiation from blood or bone marrow (BM)-derived precursors. '!-I3 The cells obtained with these techniques appear to share many of the properties of spleen-derived DC; however, to what extent this is true is still unclear. To address this question, we have undertaken a comparison of the properties of spleen and BM-derived DC in a number of assays, which are believed to be dependent on distinct properties of the APC. Indeed, spleen and BM-derived DC were similar in most respects, but also showed some remarkable differences.
MATERIALS AND METHODS
Mice. BIO.A and BALB/c mice were from breeding pairs originally obtained from Jackson Laboratories, Bar Harbor, ME and were maintained at the Animal Facility of the Wellington School of Medicine by (brother X sister) mating. The "AND" mice,14 transgenic for a T-cell receptor (TCR) specific for pigeon cytochrome c (PCC) + I-Ek, were obtained through the courtesy of Dr S. Hedrick, Department of Biology, University of California, San Diego, CA.
All cultures were in Iscove's modified Dulbecco's medium (IMDM) (Sigma Chemical Co, St Louis, MO) containing 2 mmol/L Glutamine (Sigma), 1 % penicillin-streptomycin (Sigma), 5 x Io-' moUL hnercaptoethanol (Sigma) ("complete" IMDM), and 10% fetal bovine serum (GibcoLife Technologies, Auckland, NZ). PCC was purchased from Sigma: the 88-104 fragment of PCC (KAERADLIAYLKQATAK) was obtained by in vitro chemical synthesis.
The (PCC + I-E')-specific hybridoma 2B4" was maintained in complete IMDM containing 5% fetal calf serum (FCS). The interleukin (IL)-2-dependent cell line HT-2 was maintained in complete IMDM containing 5% FCS and 100 U/mL human recombinant IL-2 (Roche, Nutley NJ).
A modification of the original method of Steinman et all6 was used. Briefly, spleen cell suspensions were prepared by digestion with a cocktail of 2.5 mg/mL collagenase (Worthington Biochemical Co, Freehold, NJ) and 0.1 % DNAse (Sigma) in serum-free medium at 37°C for 2 X 40 minutes; lowdensity cells were isolated by centrifugation over a 60% Percoll gradient ( p = 1.076). DC were further enriched by differential adherence by incubating cells on 100 mm tissue culture plates (Falcon, Oxnard. CA) in medium containing 5% FCS for 2 hours at 37°C removing the nonadherent fraction and culturing the remaining cells overnight in medium containing 5% FCS. On the next day, floating cells were collected and analyzed for percentage of DC by fluoresIn vitro culture media and reagents.
Cell lines.
Preparation of splenic DC. BM single cell suspensions were cultured in 6-well plates (Falcon) at 2 X IO6 cellsl5 mL complete IMDM containing 10% FCS, 20 nglmL granulocyte macrophagecolony stimulating factor (GM-CSF). and 20 nglmL 1L-4. Cultures were fed fresh medium and lymphokines every 2 to 3 days, and incubated at 37°C until the time of assay (6 to 8 days).
Single cell suspensions were prepared from lymph nodes or thymus as indicated, and depleted of adherent cells by incubation in 100 mm Petri dishes (Falcon) for I hour at 37°C in complete IMDM containing 5% FCS. Lymph node suspensions were further depleted of B cells by incubation with Sheep antimouse-conjugated Dynabeads (Dynal. Oslo, Norway) for 45' at 4°C. A total of 2 x 10' AND thymus or lymph node cells, or 5 x 10' BALBlc lymph node cells were plated in 96-well Rat bottom microplates (Falcon) together with the indicated number of DC and antigen as indicated. in a total volume of 200 pL. Plates were incubated for 48 or 72 hours as indicated, pulsed with I pCilwell TdR-'H (Amersham Int, Little Chalfont, UK), and incubated for a further 5 hours before harvesting. A total of 2B4 cells (IO'lwell) were incubated with the indicated numbers of DC and 1 pglmL PCC peptide in 96-well flat bottom microplates for 24 hours at 37°C. Supernatants were removed and tested for IL-2 content by incubation with the IL-2-dependent cell line HT-2 for 24 hours at 37°C; cell growth was assessed as TdR-'H uptake over 4 hours. All cultures were harvested on a Tomtec 96-well automated cell harvester (Orange, CT) and counted on a Wallac 1450 Microbeta Plus @counter (Turku, Finland).
FACS ono/yis. A total of 3 to 10 X 10.' cells were stained in 100 pL phosphate-buffered saline (PBS) containing 2% FCS and 0.01% sodium azide in 96-well U bottom microplates (LPI. Milano, Italy) at 4°C for 10'. The monoclonal antibodies N418 and 14.4.4s'' were affinity purified from tissue culture supernatants and conjugated to biotin or fluorescein isothiocyanate (FITC) as described." Anti-CD80-FITC (B7. I ) and anti-CD86-PE (B7.2) monoclonal antibodies were from Pharmingen (San Diego, CA). Streptavidin-phycoerythrin (PE) was from Jackson ImmunoResearch (West Grove, PA). All reagents were used at optimal concentration as experimentally determined. The anti-FcyRII monoclonal antibody (2.4G2)"' was used at 10 pglmL to inhibit nonspecific staining. Live cells, identified on the basis of forward scatter (FSC)-side scatter (SSC) profile and propidium iodide dye exclusion, were analyzed on a Becton-Dickinson FACSort using the CellQuest software. Instrument compensation was set in each experiment using single-color stained samples.
Growth of RM-derived DC.
T-cell stimitlation assay.^. DC from spleen or from BM cultures were compared for the ability to stimulate T-cell proliferative responses in vitro. Two different assays were used: an allogeneic MLR assay (Fig 3A) , where T cells proliferate in response to a whole array of peptide fragments naturally bound to allogeneic MHC Class 11, and an antigen specific assay (Fig 3B j, where TCR transgenic T cells respond to a specific peptide added in culture. The peptide used in this latter assay, PCC fragment 88-104, does not require processing and is able to directly bind to I-Ek on the surface of APC in the absence of further modification.
RESULTS AND DISCUSSION

FACS unalwis of splenic
DC from either spleen or BM cultures showed comparable ability to induce T-cell proliferation of MHC disparate lymph node populations (Fig 3Aj or transgenic T cells (Fig  3B) . The observed proliferative responses increased proportionally with the number of DC added in culture, with almost identical dose-response curves for either spleen or BM-derived DC. PCC peptide was used at a suboptimal concentration (1 pg/mL, Fig 3C) to allow a quantitative comparison of the data. The minimum number of DC required to induce a proliferative response ranged between 100 and 500, a number that is consistent with previously reported estimates.' '
The proliferative responses measured in the assays of Fig  3 are essentially proportional to both the number of (antigen + MHC Class 11) ligands on the surface of the APC, and the numbers of accessory and costimulatory molecules that are also required to achieve optimal T-cell proliferation. On the basis of the results in Fig 3, we conclude that the overall combination of MHC Class I1 and costimulatory molecules on spleen and BM-derived DC populations is similar, as shown by the ability of these cells to induce similar T-cell proliferative responses in unprimed T-cell populations.
Antigen processing function of spleen and BM-derived DC. We wished to establish whether spleen and BM-derived DC also had similar abilities to process native protein, and generate (antigen + MHC Class 11) ligands for recognition by T cells. To this end, we used an experimental setup similar to the one used in Fig 3B, with the exception that PCC protein, rather than peptide, was added in culture. As shown in Fig 4A , BM-derived DC were able to take up and process PCC protein and induce T-cell proliferation. Only 2 to 4 times more DC were needed to induce a similar level of T-cell proliferation when whole protein was used, rather than specific peptide. In contrast, splenic DC were very inefficient at inducing T-cell proliferation when PCC protein was used as antigen, being at least 50 times less effective than BM-derived DC. Again, PCC protein was used at a suboptimal concentration to allow a quantitative comparison of the data (Fig 48) .
Ability to process protein antigen appeared to be rapidly lost by spleen DC during culture in vitro. Spleen DC freshly isolated ex vivo and exposed to protein antigen during overnight culture in vitro (see Materials and Methods) displayed a processing ability similar to that of BM-derived DC ( shown). Because the same preparations of splenic DC were perfectly able to induce good T-cell proliferation when PCC peptide was used, according to what has been previously reported,' we conclude that spleen-derived DC rapidly lose their ability to take up and process native proteins. In contrast, BM-derived DC can efficiently process and present protein antigen even after extended culture in vitro.
Ability of splenic and BM-derived DC to stimulate the Tcell hybridoma 2B4. The assays described in Figs 3 and 4 use as a readout the proliferation of T cells from nonimmunized mice. This response requires that both an antigenspecific and a costimulatory signal are delivered to the T cell from the APC. To better define the contribution of (antigen + MHC Class 11) and costimulatory signals to the responses measured, we also compared the APC capacity of splenic and BM-derived DC in a T-cell hybridoma assay. The Tcell hybridoma 2B4 has virtually identical (antigen + MHC Class 11) specificity to the TCR transgenic T cells, but, like all hybridomas, it does not require costimulatory signals in order to respond." As shown in Fig 6 , when compared on a per cell basis, DC from either spleen or BM cultures induced similar secretion of IL-2 by 2B4 hybridoma cells. This implies that the total amounts of (antigen + MHC) expressed by the two cell types are similar. Indirectly, the data also suggest that the costimulatory signals provided by the two cell types are again similar, as unprimed transgenic T cells (Fig 3B) , and a T-cell hybridoma of similar specificity ( Fig  6) show identical preferences for APC type.
Methods for the in vitro growth of murine dendritic cells from BM precursors have been de~cribed''~'~~'~ and are becoming increasingly popular. They offer a number of clear advantages over the traditional methods of purifica-
Conclusions.
tion from lymphoid organs: the procedure is simple, and DC can be reproducibly obtained at high purity and in large numbers from a small number of donors. Due to these reasons, BM-derived DC are quickly becoming the preferred DC for in vivo and in vitro studies. However, it is unclear how closely this in vitro obtained population resembles its in vivo counterpart.
We have undertaken a comparison of the antigen presenting function of DC isolated from murine spleen, or cultured in vitro from BM precursors. We have chosen to concentrate our study on three distinct properties of APC: expression of (antigen + MHC Class 11) TCR ligands, capacity to process and present protein antigen, and expression of costimulatory molecules. We have observed that BM-derived DC were as efficient as spleen ones at inducing the proliferation of a peptide-specific TCR-transgenic T-cell population and a polyclonal allogeneic T-cell population. The two DC populations were also equally effective at inducing IL-2 secretion by a peptide-specific T-cell hybridoma. We conclude that BM-derived DC must express high levels of (antigen + MHC Class 11) ligands and costimulatory molecules, which are functionally comparable to the levels expressed on spleen DC. Indeed, FACS staining experiments showed that BMderived DC do express high levels of MHC Class I1 and costimulatory molecules such as B7.1 and B7.2. This high T-cell stimulatory capacity is perhaps surprising, as it might not have been expected that in vitro-generated population could be functionally as efficient as its ex vivo-derived counterpart. It suggest that BM-derived DC are equivalent to the "mature" DC found in lymphoid organs, which have For personal use only. on October 3, 2017. by guest www.bloodjournal.org From upregulated their costimulatory molecules and show good T-cell stimulatory Besides having at least as good a T-cell stimulatory ability, BM-derived DC were also significantly better than spleen DC at processing and presenting a protein antigen. While the antigen processing ability of spleen DC was rapidly lost during the overnight culture required for their isolation, BMderived DC maintained their antigen processing ability over several days of in vitro culture, suggesting an actual physiological difference between the two cell populations. A good antigen processing ability was recently reported also for human DC cultured from blood precursorsz3 and is consistent with the observation that murine BM-derived DC have phagocytic activity and can sensitize mice to bacillus Calmette-G~erin.'~ Such antigen processing ability has so far been considered to be characteristic of the immature forms of DC, the Langerhans cells, which are resident in tissues,' and is, therefore, somewhat at odds with the high T-cell stimulatory ability reported above. According to current understanding, DC's antigen processing and costimulatory ability are inversely related. It could then be that the acquisition and maintenance of the stimulatory and antigen processing properties of DC are regulated by cell mediated and soluble factors that are differentially present in culture and in vivo.
In conclusion, DC derived from BM cultures combine the high T-cell stimulatory ability of mature DC with the antigen processing capacity typical of cells, such as dendritic Langerhans cells that reside in the periphery. This unusual combination makes BM-derived DC a potentially very useful tool for experiments requiring the generation of antigen-specific T cells, in vitro and possibly in vivo.
